10x Genomics Inc - Ordinary Shares - Class A
TXG
Market Cap$2.78B
Close$
$42.06
65.8% upside
Current Fair Value
65.8% upsideUndervalued by 65.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.78 Billion |
|---|---|
| Enterprise Value | $2.41 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-2.24 |
| Beta | 2.07 |
| Outstanding Shares | 105,651,593 |
| Avg 30 Day Volume | 1,931,662 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -10.51 |
|---|---|
| PEG | -57.96 |
| Price to Sales | 5.07 |
| Price to Book Ratio | 4.23 |
| Enterprise Value to Revenue | 3.85 |
| Enterprise Value to EBIT | -11.25 |
| Enterprise Value to Net Income | -10 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
ESG Score
No data
About 10x Genomics Inc
CEO: Serge Saxonov